Vaccines, Attenuated (administration & dosage) < Vaccines, Attenuated (adverse effects) < Vaccines, Attenuated (biosynthesis)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Vaccines, Attenuated (adverse effects)

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000160 (2018)	Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000533 (2015)	Larisa Rudenko [Russie] ; Irina Isakova-Sivak	Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
000A76 (2012)	Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko	Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
000A85 (2012)	Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao	An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000C38 (2011)	Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov	Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
000F07 (2010)	Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao	A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
001132 (2009)	Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao	A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001225 (2008)	Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky	Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
001496 (2006)	Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. Seong	Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
002137 (1989)	M L Clements [États-Unis] ; S D Sears ; K. Christina ; B R Murphy ; M H Snyder	Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.
002264 (1988)	Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. Murphy	Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers
002271 (1988)	M. H. Snyder ; R. F. Betts ; D. Deborde ; E. L. Tierney ; M. L. Clements ; D. Herrington ; S. D. Sears ; R. Dolin ; H. F. Maassab ; B. R. Murphy	Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines
002B01 (1976)	J M Gwaltney	The use of live attenuated influenza vaccine ts-1(E) in man.
002D90 (????)	F I Polezhaev ; G N Budilovski ; L M Garmashova ; Iu R. Rome Ko-Gurko ; A Iu Egorov	[Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
002E24 (????)	I V Kiseleva ; A I Klimov ; E P Grigor'Eva ; N V Larionova ; G I Aleksandrova ; L G Rudenko	[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Vaccines, Attenuated (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Vaccines, Attenuated (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Vaccines, Attenuated (adverse effects)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021